Sentante successfully completed a GLP study!
Our animal study exceeded expectations and showcased extraordinary results. This milestone marks an important step forward in our journey. We want to say a heartfelt
April 17, 2024
Sensory,
Teleoperated,
Intuitive
Teleoperated,
Intuitive
The first fully-robotic
teleoperated system
for endovascular interventions
Sentante
Endovascular procedures performed remotely with uncompromised feedback force
View Video
3:00
Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management
Remote interventions reduce the response time for
stroke, heart attack
and bleeding
Uniqueness
of Sentante:
of Sentante:
Disruptive technology:
01
Fully robotic
The manipulation of three endovascular instruments simultaneously allows the entire procedure to be performed robotically.
02
Teleoperated
The endovascular procedure can be performed from a different room or hospital.
03
Haptic feedback
Physicians can feel the catheter and guidewire just as if they were standing near the patient
04
Universal compatibility
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer
05
Precise manipulation
Accurate, submillimetric instrument positioning and stent placement
06
Ergonomic workplace
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons
07
No additional training is needed
Physicians interface with the robot is via the same endovascular instruments as in a manual procedure
08
Occupational hazards free
Medical personnel are not exposed to hazardous X-rays
Future
perspectives
perspectives
01
Training module
Realistic training platform with haptic feedback for residents and new physicians
02
Device testing platform
Simulated models for safe, affordable testing and training of endovascular devices
03
Artificial intelligence based automation
Semi-automated routine tasks such as catheter or guidewire exchange
About Us
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Management Team
Edvardas Satkauskas
CEO
Experienced entrepreneur, Co-founder of Inovatyvi Medicina
Dr. Tomas Baltrūnas
CMO
Vascular surgeon, Founder of Inovatyvi Medicina
Perry Van Rijsingen
Board Member
Dr. Evaldas Kalvaitis
COO
Co-founder of Inovatyvi Medicina
Vilius Dambrauskas
CTO
Co-founder of Inovatyvi Medicina
Vaidas Labunskas
Chief Mechanical Engineer
Co-founder of Inovatyvi Medicina
Ugnė Gurskė
Human Resources Manager
Advisory Board Members
Dr. Ricardo A. Hanel
Medical Advisory Board Member
![bandymas4[4382]](https://sentante.com/wp-content/uploads/elementor/thumbs/bandymas44382-q4uru2vgjr8kaa9e5haw4af639rkgxg1vvurfx2xi8.png "bandymas4[4382]")
Dr. Michael Lichtenberg
Medical Advisory Board Member
![David-Liebeskind[4385]](https://sentante.com/wp-content/uploads/elementor/thumbs/David-Liebeskind4385-q4usqcnz6zeywbdtpfhrq58wbip8qtkabm6wlx8bvk.png "David-Liebeskind[4385]")
Dr. David Liebeskind
Medical Advisory Board Member
![Giovanni-gera[4434]](https://sentante.com/wp-content/uploads/elementor/thumbs/Giovanni-gera4434-q4uw1a6txc81w4mo8c7epmti5mi5o4pn09rllaw2lc.png "Giovanni-gera[4434]")
Dr. Giovanni Torsello
Medical Advisory Board Member
![Peter-Shneider[4388]](https://sentante.com/wp-content/uploads/elementor/thumbs/Peter-Shneider4388-q4ussc3pme4reoi24adezn7xgsx4ztfvxfrt2yaeqo.png "Peter-Shneider[4388]")
Dr. Peter Schneider
Medical Advisory Board Member
Matt Lemay
Business Advisory Board Member
Christopher Prentice
Business Advisory Board Member
Route to
market
market
Expecting launch in 2024
01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency
01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application
EPO
01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03
First patent application
01
Work in progress
01
Pre-clinical animal testing
02
Continuing patent applications
01
Expected first in human procedure
News
Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care
Sentante announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the
January 3, 2024
Dr. Ricardo A. Hanel has joined our Medical Advisory Board!
Thrilled to announce that Ricardo Hanel has joined our Medical Advisory Board! With over two decades of experience in shaping endovascular neurosurgery, Dr. Hanel brings his knowledge
November 26, 2023
Paris Vascular Insights Symposium, 2023
Paris Vascular Insights Symposium #PVI2023 took center stage at the same venue as Paris Fashion Week! 🌟 While the runway dazzled with style, our very own Tomas Baltrunas rocked the
November 10, 2023
MedTech Innovator, California, 2023
Absolutely thrilled to participate in MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry.
October 28, 2023
XIII-International-Conference of the Polish Society for Vascular Surgery, Warsaw, 2023
🌊 Riding the Innovation Wave at #PTCHN2023! Tomas Baltrunas presented Sentante at the prestigious XIII-International-Conference of the Polish Society for Vascular Surgery in Warsaw, Poland. Huge thanks to all
September 15, 2023
Society of Robotic Surgery | SRS annual meeting, 2023
Proud moment at Society of Robotic Surgery | SRS annual meeting! Tomas Baltrunas took the stage to present Sentante unveiling some of the most remarkable features that set it apart
September 4, 2023
ICCA Stroke Conference, 2023
Sentante presented at ICCA Stroke Conference, 2023 – thrilling! ICCA Stroke brought together leading minds in the field to discuss groundbreaking advancements in stroke research and treatment. 🎯All united
August 28, 2023
MedTech Innovator Startup Showcase 2023, San Francisco
🌉 San Francisco – the perfect meeting point for groundbreaking ideas and transformative collaborations! We are happy to share that we’ve landed ourselves a spot
June 28, 2023
Christopher Prentice has joined our Business Advisory Board!
We are excited to announce that Christopher Prentice has joined our business advisory board! With over 20 years of exceptional experience in both well-established multinational companies and
June 13, 2023